Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

November 2023Thomas R. CollinsMolecules that link cancer driver genes and promoters of cell death genes produce potent killing of diffuse large B-cell lymphoma (DLBCL) cells, according to findings pub

Updated on: February 18,2024

Molecule Linking Cancer Driver and Cell Death Genes May Be Effective Against DLBCL

November 2023Thomas R. CollinsMolecules that link cancer driver genes and promoters of cell death genes produce potent killing of diffuse large B-cell lymphoma (DLBCL) cells, according to findings pub

Updated on:February 18,2024

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

Updated on: February 20,2024

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma

by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou

Updated on:February 20,2024

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Updated on: January 22,2024

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Updated on:January 22,2024

An unexpected journey reveals a potent way to attack tumors

by Nancy Fliesler,Children's Hospital BostonSenescence inducer CuSO4, which causes ER stress, activates NKp46- and NKG2D-dependent NK killing, but 4-PBA, which induces senescence without ER

Updated on: February 23,2024

An unexpected journey reveals a potent way to attack tumors

by Nancy Fliesler,Children's Hospital BostonSenescence inducer CuSO4, which causes ER stress, activates NKp46- and NKG2D-dependent NK killing, but 4-PBA, which induces senescence without ER

Updated on:February 23,2024

Researchers extend effectiveness of immunotherapy to more lung cancer patients

by The Spanish National Cancer Research CentreCredit: CC0 Public DomainImmunotherapy, the strategy for triggering the patient's own immune system to attack cancer, is proving effective for mo

Updated on: March 12,2024

Researchers extend effectiveness of immunotherapy to more lung cancer patients

by The Spanish National Cancer Research CentreCredit: CC0 Public DomainImmunotherapy, the strategy for triggering the patient's own immune system to attack cancer, is proving effective for mo

Updated on:March 12,2024

Five ways research can prevent cancer

by Sophia Lowes,Cancer Research UKCredit: Jill WatsonWe recently published landmark researchshowing how lifestyle can influence our risk of cancer, and what factors could help prevent it.

Updated on: March 01,2024

Five ways research can prevent cancer

by Sophia Lowes,Cancer Research UKCredit: Jill WatsonWe recently published landmark researchshowing how lifestyle can influence our risk of cancer, and what factors could help prevent it.

Updated on:March 01,2024

Prostate tumor biology may be influenced by genetic ancestry

byAmerican Association for Cancer ResearchSample collection sites and genetic admixture analysis. A, At clinical sites across Nigeria, 45 samples were collected. B, Admixture v1.3.0 was used to

Updated on: January 02,2024

Prostate tumor biology may be influenced by genetic ancestry

byAmerican Association for Cancer ResearchSample collection sites and genetic admixture analysis. A, At clinical sites across Nigeria, 45 samples were collected. B, Admixture v1.3.0 was used to

Updated on:January 02,2024

Can the body's own 'killer torpedoes' derived from NK cells fight cancer?

by Elin Martine Doeland,University of OsloAn NK cell meeting a cancer cell. The killer torpedoes, illustrated with chocolates, attack the cancer cell. The image was taken at the Medical research

Updated on: December 28,2023

Can the body's own 'killer torpedoes' derived from NK cells fight cancer?

by Elin Martine Doeland,University of OsloAn NK cell meeting a cancer cell. The killer torpedoes, illustrated with chocolates, attack the cancer cell. The image was taken at the Medical research

Updated on:December 28,2023

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on: January 23,2024

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on:January 23,2024

Unhealthy gut sets stage for breast cancer to spread, research reveals

byUniversity of VirginiaCredit: Unsplash/CC0 Public DomainAn unhealthy gut triggers changes in normal breast tissue that helps breast cancer spread to other parts of the body, new research from

Updated on: January 16,2024

Unhealthy gut sets stage for breast cancer to spread, research reveals

byUniversity of VirginiaCredit: Unsplash/CC0 Public DomainAn unhealthy gut triggers changes in normal breast tissue that helps breast cancer spread to other parts of the body, new research from

Updated on:January 16,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on: January 29,2024

New tools to manage rare eye cancer

by University College DublinTumor secretion of IL-6, IL-13, VEGF-A, and PlGF correlate with clinical characteristics in ex vivo, control-treated, primary UM patient tumors. (A) Schematic of the e

Updated on:January 29,2024

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Updated on: January 22,2024

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Updated on:January 22,2024